4.2 Article

Novel Compound Heterozygous Spatacsin Mutations in a Greek Kindred with Hereditary Spastic Paraplegia SPG11 and Dementia

Journal

NEURODEGENERATIVE DISEASES
Volume 16, Issue 5-6, Pages 373-381

Publisher

KARGER
DOI: 10.1159/000444715

Keywords

Diffusion tensor imaging; Hereditary spastic paraparesis; Leukoencephalopathy; Neurogenetics; Spatacsin

Funding

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003128] Funding Source: NIH RePORTER

Ask authors/readers for more resources

SPG11 belongs to the autosomal recessive hereditary spastic paraplegias (HSP) and presents during childhood or puberty with a complex clinical phenotype encompassing learning difficulties, ataxia, peripheral neuropathy, amyotrophy, and mental retardation. We hereby present the case of a 30-year old female patient with complex autosomal recessive HSP with thinning of the corpus callosum (TCC) and dementia that was compound heterozygous with two novel mutations in the SPG11 gene. Sequence analysis of the SPG11 gene revealed two novel mutations in a compound heterozygous state in the index patient (c.2431C>T/p.Gln811Ter and c.6755_6756insT/p.Glu2252Aspfs*88). MRI showed abnormal TCC, white matter (WM) hyperintensities periventricularly, and the 'ears of the lynx' sign. Diffusion tensor imaging showed a mild-to-moderate decrease in fractional anisotropy and an increase in mean diffusivity in WM compared to age-matched controls, while magnetic resonance spectroscopy showed abnormal findings in affected WM with a decrease in N-acetyl-aspartate in WM regions of interest. This is the first SPG11 kindred from the Greek population to be reported in the medical literature. (C) 2016 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set

Chiara Marzi, Alessandro d'Ambrosio, Stefano Diciotti, Alvino Bisecco, Manuela Altieri, Massimo Filippi, Maria Assunta Rocca, Loredana Storelli, Patrizia Pantano, Silvia Tommasin, Rosa Cortese, Nicola De Stefano, Gioacchino Tedeschi, Antonio Gallo

Summary: This study used machine learning techniques to assess the relationship between brain MRI structural volumes and cognitive deficits in MS patients, and found that damage to gray matter structures is most closely related to cognitive performance.

HUMAN BRAIN MAPPING (2023)

Article Clinical Neurology

Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis

Elisabetta Pagani, Loredana Storelli, Patrizia Pantano, Nikolaos Petsas, Gioacchino Tedeschi, Antonio Gallo, Nicola De Stefano, Marco Battaglini, Maria A. Rocca, Massimo Filippi

Summary: In patients with multiple sclerosis, the determination of brain atrophy in specific regions is clinically relevant. However, analyzing large datasets is challenging due to the increased variability in multicenter data. This study compared different methods to correct for center effects and investigated regional gray matter volume in patients with relapsing-remitting multiple sclerosis using a large multicenter dataset. The results showed that harmonization based on subsampling effectively reduced the residuals of the statistical model applied, and the multicenter results were more robust compared to findings from single-center analysis, highlighting the importance of data repositories from multiple centers.

JOURNAL OF NEUROLOGY (2023)

Article Neurosciences

Discovering functional connectivity features characterizing multiple sclerosis phenotypes using explainable artificial intelligence

Muhammad Abubakar Yamin, Paola Valsasina, Jacopo Tessadori, Massimo Filippi, Vittorio Murino, Maria A. Rocca, Diego Sona

Summary: Multiple sclerosis (MS) is a neurological condition characterized by brain damage and reorganization of brain networks. This article describes a system that uses machine learning to classify different MS phenotypes and identify relevant functional connections. The proposed framework shows significant classification performance for all MS phenotypes and successfully identifies relevant alterations in functional connectivity.

HUMAN BRAIN MAPPING (2023)

Article Biochemistry & Molecular Biology

SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients

Elena Berrone, Giovanna Chiorino, Francesca Guana, Valerio Benedetti, Claudia Palmitessa, Marina Gallo, Andrea Calvo, Federico Casale, Umberto Manera, Alessandra Favole, Paola Crociara, Camilla Testori, Valerio Carta, Carlotta Tessarolo, Antonio D'Angelo, Giovanni De Marco, Maria Caramelli, Adriano Chio, Cristina Casalone, Cristiano Corona

Summary: ALS is a complex disease with delayed diagnosis and limited therapeutic options. The SOMAscan assay was used to identify differential expression of proteins in ALS patients, and 42 proteins were found to be significantly different. Four upregulated proteins were selected and validated in an overlapping cohort of patients. These proteins may provide insight into ALS pathogenesis and serve as potential candidates for targeted therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset

Loredana Storelli, Elisabetta Pagani, Patrizia Pantano, Claudia Piervincenzi, Gioacchino Tedeschi, Antonio Gallo, Nicola De Stefano, Marco Battaglini, Maria A. Rocca, Massimo Filippi, INNI Network

Summary: This study compared different methods for measuring whole-brain and gray matter atrophy using the INNI dataset, and found that SPM-v12 and Jim-v8 software showed significant agreement in assessing gray matter volumes and atrophy progression.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Review Clinical Neurology

The future of ALS diagnosis and staging: where do we go from here?

Angela Genge, Adriano Chio

Summary: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder with difficulties in diagnosis and prognosis assessment. This article provides a clinical overview of balancing evidence-based medicine and patient needs, as well as explores factors to improve diagnostic efficiency and assessment of disease progression.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2023)

Article Clinical Neurology

Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline

Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin, Camillo Marra, Flavio Nobili, Lucilla Parnetti, Federica Agosta

Summary: Currently, no disease-modifying therapies are available for Alzheimer's disease (AD) in Europe. However, evidence from clinical trials suggests that anti-beta amyloid (Aβ) monoclonal antibodies (mAbs) may be authorized for marketing in the near future. A group of prominent AD clinical experts in Italy met to discuss patient selection and management strategies, recognizing the need for significant changes in dementia care to implement disease-modifying therapies. They emphasized the importance of a biological diagnosis using amyloid- and tau-related biomarkers, as well as specialized diagnostic work-up and exclusion criteria assessment by neurology specialists. The experts also proposed a reorganization of dementia and cognitive decline centers into three levels with defined tasks and requirements.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study

Matteo Azzimonti, Paolo Preziosa, Elisabetta Pagani, Paola Valsasina, Nicolo Tedone, Carmen Vizzino, Maria A. A. Rocca, Massimo Filippi

Summary: This study applied a longitudinal multiparametric MRI approach to investigate the mechanisms associated with cognitive worsening in MS patients. The results suggest that GM atrophy progression and functional impoverishment may be the main factors underlying cognitive worsening in MS.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study

Monica Margoni, Elisabetta Pagani, Paolo Preziosa, Mor Gueye, Matteo Azzimonti, Maria A. Rocca, Massimo Filippi

Summary: This study used multimodal MRI to investigate the regional distribution of different pathological processes in the brain white and gray matter of relapse-onset multiple sclerosis (MS) patients. The results showed that compared to healthy controls, relapsing-remitting MS (RRMS) patients exhibited white matter, deep gray matter, and cortical atrophy, as well as significantly lower MTR and T1w/T2w ratio in periventricular and infratentorial white matter, deep gray matter, and several cortical areas. Secondary progressive MS (SPMS) patients showed more severe deep gray matter and widespread cortical atrophy, lower MTR of periventricular white matter, deep gray matter, and cerebellum, lower T1w/T2w ratio of fronto-temporal white matter regions, lower ICV_f of some fronto-tempo-occipital white matter and cortical areas, and increased QSM and T1w/T2w ratio in the pallidum.

JOURNAL OF NEUROLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection

Piet M. Bouman, Samantha Noteboom, Fernando A. Nobrega Santos, Erin S. Beck, Gregory Bliault, Marco Castellaro, Massimiliano Calabrese, Declan T. Chard, Paul Eichinger, Massimo Filippi, Matilde Inglese, Caterina Lapucci, Andrzej Marciniak, Bastiaan Moraal, Alfredo Morales Pinzon, Mark Muehlau, Paolo Preziosa, Daniel S. Reich, Maria A. Rocca, MennoM. Schoonheim, Jos W. R. Twisk, Benedict Wiestler, Laura E. Jonkman, Charles R. G. Guttmann, Jeroen J. G. Geurts, Martijn D. Steenwijk

Summary: This study evaluated the detection ability of artificial intelligence-generated double inversion recovery (DIR) and phase-sensitive inversion recovery (PSIR) images for cortical and juxtacortical multiple sclerosis lesions in a multicenter setting, compared with MRI-acquired images. The results showed that the AI-generated images performed well compared to the MRI-acquired images and demonstrated good reliability in a multicenter setting, with good interpretative agreement between readers and centers.

RADIOLOGY (2023)

Article Geriatrics & Gerontology

Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis

Umberto Manera, Maurizio Grassano, Enrico Matteoni, Alessandro Bombaci, Rosario Vasta, Francesca Palumbo, Maria Claudia Torrieri, Paolo Cugnasco, Cristina Moglia, Antonio Canosa, Adriano Chio, Andrea Calvo

Summary: Respiratory failure is a common cause of death in ALS patients, and its occurrence varies among patients with different phenotypic features. Early predictors of respiratory failure are important to initiate NIV. In this study, serum chloride values at diagnosis were evaluated as prognostic biomarkers for overall survival and NIV adaptation in ALS patients. Analysis showed a significant correlation between serum chloride and various clinical features, and serum chloride value at diagnosis was found to significantly influence survival and time to NIV start. Serum chloride analyzed at diagnosis can serve as a low-cost marker for predicting respiratory decompensation in ALS patients.

FRONTIERS IN AGING NEUROSCIENCE (2023)

Article Clinical Neurology

COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success

Jeremy M. Shefner, Ammar Al-Chalabi, Jinsy A. Andrews, Adriano Chio, Mamede De Carvalho, Bettina M. Cockroft, Philippe Corcia, Philippe Couratier, Merit E. Cudkowicz, Angela Genge, Orla Hardiman, Terry Heiman-Patterson, Robert D. Henderson, Caroline Ingre, Carlayne E. Jackson, Wendy Johnston, Noah Lechtzin, Albert Ludolph, Nicholas J. Maragakis, Timothy M. Miller, Jesus S. Mora Pardina, Susanne Petri, Zachary Simmons, Leonard H. Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I. Malik, Lisa Meng, Tyrell J. Simkins, Jenny Wei, Andrew A. Wolff, Stacy A. Rudnicki

Summary: The objective of this study is to determine the target population and optimize the study design for the phase 3 clinical trial of reldesemtiv in ALS participants. The phase 2 study, FORTITUDE-ALS, showed that reldesemtiv had a significant effect on participants with intermediate and fast disease progression, leading to the implementation of specific eligibility criteria and design features in the phase 3 trial, COURAGE-ALS, to increase sensitivity in detecting treatment effects and reduce burden on participants and study sites.

AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2023)

Article Cardiac & Cardiovascular Systems

Potential Cardiologic Protective Effects of Acetylcholinesterase Inhibitors in Patients With Mild to Moderate Dementia

Lorenzo Rampa, Roberto Santangelo, Carlo Gaspardone, Alice Cerutti, Giuseppe Magnani, Francesco Piscazzi, Giulia Sgherzi, Giorgio Fiore, Massimo Filippi, Federica Agosta, Alberto Margonato, Gabriele Fragasso

Summary: AChE-I treatment in patients with dementia may reduce the risk of cardiovascular events, particularly heart failure and myocardial revascularization. The use of AChE-I in dementia patients may be protective for cardiovascular outcomes.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Clinical Neurology

Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study

Serena Ruggieri, Luca Prosperini, Sarmad Al-Araji, Pietro Osvaldo Annovazzi, Alvino Bisecco, Olga Ciccarelli, Nicola De Stefano, Massimo Filippi, Vinzenz Fleischer, Nikos Evangelou, Christian Enzinger, Antonio Gallo, Afagh Garjani, Sergiu Groppa, Shalom Haggiag, Michael Khalil, Matteo Lucchini, Massimiliano Mirabella, Xavier Montalban, Carlo Pozzilli, Paolo Preziosa, Jordi Rio, Maria A. Rocca, Alex Rovira, Maria L. Stromillo, Mauro Zaffaroni, Carla Tortorella, Claudio Gasperini

Summary: Early relapses and substantial MRI activity in the first year of treatment are associated with worse short-term outcomes in patients treated with some of the oral DMTs.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Phenotypes and clinical subgroups in vestibular migraine: a cross-sectional study with cluster analysis

Roberto Teggi, Bruno Colombo, Federica Cugnata, Roberto Albera, Giacinto Asprella Libonati, Cristiano Balzanelli, Augusto Pietro Casani, Iacopo Cangiano, Marco Familiari, Sergio Lucisano, Marco Mandala, Giampiero Neri, Rudi Pecci, Mario Bussi, Massimo Filippi

Summary: The aim of this study was to collect phenotypes and clinical variability of 244 patients with vestibular migraine (VM) in order to differentiate subtypes. VM is a common episodic vertigo disorder with varying duration of attacks and accompanying symptoms. Diagnosis is mainly based on clinical history with associated migrainous headache or photo/phonophobia.

NEUROLOGICAL SCIENCES (2023)

No Data Available